美吾華 1731.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 1731)
1731
美吾華
22.90D
0.44%
(0.10)
1731 Value Score
3
24
15
Average Growth
- AI analysis rates 1731 with a medium value score of 3.
- It is mainly due to stable revenue growth, but with concerns regarding lower ROE.
- Over the past 3 months, 1731 has maintained an average value rating of 3.7, slightly lower than the rating of 4.3 over the past 3 years, indicating decreasing growth opportunities for enterprise value.
- Compared to all stocks in the Biotech. & Medical sector, 1731 has a medium value rating.
1731 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/05/09 (Weekly Update)
1731 Financial Forecast
Unit : TWD
Update to 2025/5/9 (Quarterly Update)
1731 Earnings Table
No related data records
1731 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
1731 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 1731 from 2007/01 till Now
- 180.06%
- Cumulative Return
- 5.93%
- Annual Return
- 22.36%
- Volatility
- 0.27
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 4)
| 1731 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | 50% | 46% | 53% |
| Avg Return | 40.9% | 21.1% | 45.4% |
| Avg Profit | 87.2% | 72.2% | 102.9% |
| Avg Loss | -5.4% | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | 1613.4% | 322.8% | 505.8% |
Update to 2025/5/10 (Daily Update)